Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leiomyosarcoma of the Corpus Uteri”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01958580
What this trial is testing

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Who this might be right for
Stage IA Uterine SarcomaStage IB Uterine SarcomaStage IC Uterine Sarcoma+8 more
Albert Einstein College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT00101127
What this trial is testing

Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00414076
What this trial is testing

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Who this might be right for
LeiomyosarcomaUterine Neoplasm
M.D. Anderson Cancer Center 9
Not applicableStudy completedNCT00614835
What this trial is testing

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Who this might be right for
Uterine LeiomyosarcomaUterine Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00053794
What this trial is testing

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerSarcoma
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Study completedNCT00031629
What this trial is testing

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT00025441
What this trial is testing

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)Study completedNCT01637961
What this trial is testing

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05432791
What this trial is testing

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

Who this might be right for
Locally Advanced Uterine Corpus LeiomyosarcomaMetastatic Uterine Corpus LeiomyosarcomaStage III Uterine Corpus Leiomyosarcoma AJCC v8+2 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Looking for participantsNCT07467772
What this trial is testing

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Who this might be right for
Uterine SarcomaUterine LeiomyosarcomaEndometrial Stromal Sarcoma+6 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00379145
What this trial is testing

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 20
Testing effectiveness (Phase 2)UnknownNCT00033709
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

Who this might be right for
Sarcoma
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003334
What this trial is testing

Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
NYU Langone Health
Large-scale testing (Phase 3)Ended earlyNCT01533207
What this trial is testing

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Who this might be right for
Stage I Uterine Sarcoma AJCC v7Uterine Corpus Leiomyosarcoma
Gynecologic Oncology Group 38
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT02428192
What this trial is testing

Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma

Who this might be right for
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT05649956
What this trial is testing

Letrozole in Uterine Leiomyosarcoma

Who this might be right for
Uterine Leiomyosarcoma
GOG Foundation 40
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Looking for participantsNCT07076186
What this trial is testing

Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS

Who this might be right for
Uterine Leiomyosarcoma
M.D. Anderson Cancer Center 48
Next Page